Papers
2
Total Citations
66
H-Index
2
About
Dr. Xianjie Tan is a leading surgical oncologist whose research focuses on optimizing treatment strategies for early-stage cervical cancer, with a particular emphasis on the comparative effectiveness of minimally invasive versus open surgical approaches. Dr. Tan’s major contributions center on designing and implementing rigorous, multicenter randomized controlled trials to address critical controversies in gynecologic oncology. Notably, their work directly responds to landmark findings like the LACC trial, which questioned the safety of minimally invasive radical hysterectomy. Dr. Tan’s 2019 protocol for a phase III trial comparing surgical approaches has garnered 56 citations, underscoring its significance in shaping clinical practice. Further extending this line of inquiry, their 2020 protocol for a randomized trial comparing minimally invasive versus open radical trachelectomy—a fertility-sparing procedure—has earned 10 citations, highlighting its importance for younger patients. By establishing evidence-based guidelines for surgical decision-making, Dr. Tan is helping to balance oncologic safety with quality of life. Their methodical, protocol-driven research is instrumental in defining the future standard of care for cervical cancer surgery in China and globally.
Research Focus
Key Achievements
Top Papers
- 1
- 2